Pharmafile Logo

Lucid Group’s winning formula is recognised at Communiqué 2017

Lucid Group’s commitment to improving patient outcomes across the globe was recognised at the 2017 Communiqué Awards in London last night. The agency won the awards for Excellence in Communications via Meetings for their long-running global programme, ICE, designed to grow and support best practice in IBD units.

Jan Steele (Lucid Co-founder and COO) commented that, “2017 has been our most successful year to date. We celebrated our 10-year anniversary in February, received a Queen’s Award for Enterprise in April, launched our strategic consultancy in May and our metrics suite in June. For our work to be continually recognised as industry-leading is fantastic. And to work with clients who inspire and challenge us is a privilege. Together we have produced some magical work”.

- PMLiVE

This content was provided by Lucid Group Communications Limited

Company Details

 Latest Content from  Lucid Group Communications Limited 

Lucid celebrate big wins at PMEA 2015

Success for Lucid at PMEA 2015

Lucid invests in their Futures programme with a new hire

Lucid Group continues their expansion

Janus kinase inhibitors are amongst the most read abstracts at the American College of Rheumatology 2015

Rheumatologists eagerly await trial data for Janus kinase inhibitors

Making a difference to patients with IBD

Changing lives with medical education

Lucid Group showcases new KOL identification and mapping tool

Advancing Expert identification with digital new tool from Lucid Group

Lucid CEO discusses his inspiration and passion for changing patients’ lives

Changing patients' lives with innovative methodologies in medical education

Lucid Group starts new trend for CME in IBD education

A tailored educational event in IBD